Paul R Edick Insider Trading $ITRM Iterum Therapeutics plc
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Paul R Edick.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Paul R Edick. Paul R Edick is Director in PDL BIOPHARMA, INC. ($PDLI) and Director in NEWLINK GENETICS CORP ($NLNK) and See Remarks in XERIS PHARMACEUTICALS INC ($XERS) and Director in Sucampo Pharmaceuticals, Inc. ($SCMP) and Director in Milestone Pharmaceuticals Inc. ($MIST) and Director in Neos Therapeutics, Inc. ($NEOS) and Director in Iterum Therapeutics plc ($ITRM).
Paul R Edick in Iterum Therapeutics plc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Paul R Edick: Director
Holdings: 31,390 shares
Latest Transaction: May 29 2019
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Paul R Edick in Iterum Therapeutics plc
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ITRM, NLNK, MIST, NEOS, PDLI, SCMP, XERS
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 29 2019 | ITRM | Iterum Therapeutic ... | Edick Paul R | Director | Option Exercise | M | 0.00 | 6,154 | 0 | 0 | |
| May 29 2019 | ITRM | Iterum Therapeutic ... | Edick Paul R | Director | Buy | M | 0.00 | 6,154 | 0 | 31,390 | 25.2 K to 31.4 K (+24.39 %) |
| Aug 27 2018 | ITRM | Iterum Therapeutic ... | Edick Paul R | Director | Buy | P | 10.44 | 500 | 5,219 | 25,236 | 24.7 K to 25.2 K (+2.02 %) |
| May 30 2018 | ITRM | Iterum Therapeutic ... | Edick Paul R | Director | Option Exercise | C | 0.00 | 1,591 | 0 | 0 | |
| May 30 2018 | ITRM | Iterum Therapeutic ... | Edick Paul R | Director | Option Exercise | C | 0.00 | 4,050 | 0 | 0 | |
| May 30 2018 | ITRM | Iterum Therapeutic ... | Edick Paul R | Director | Option Exercise | C | 0.00 | 15,913 | 0 | 0 | |
| May 30 2018 | ITRM | Iterum Therapeutic ... | Edick Paul R | Director | Buy | C | 0.00 | 1,591 | 0 | 24,736 | 23.1 K to 24.7 K (+6.87 %) |
| May 30 2018 | ITRM | Iterum Therapeutic ... | Edick Paul R | Director | Buy | C | 0.00 | 4,050 | 0 | 23,145 | 19.1 K to 23.1 K (+21.21 %) |
| May 30 2018 | ITRM | Iterum Therapeutic ... | Edick Paul R | Director | Buy | C | 0.00 | 15,913 | 0 | 19,095 | 3.2 K to 19.1 K (+500.09 %) |
| May 29 2018 | ITRM | Iterum Therapeutic ... | Edick Paul R | Director | Option Exercise | A | 0.00 | 6,154 | 0 | 6,154 |
Page: 1